Long-Term Data Supports CAR T-Cell Therapy for CLL Treatment
Introduction Chronic Lymphocytic Leukemia (CLL), a type of blood cancer, presents a significant challenge in hematology and oncology. Characterized by the excessive proliferation of abnormal lymphocytes in the blood and bone marrow, CLL often leads to a weakened immune system, making patients more susceptible to infections and other complications. Traditional treatment options for CLL, such … Read more
